GGrantIndex
← Leaderboards

University Of Saskatchewan

Saskatoon, SK

Compare ↔
$3,908,904
Total funding
12
Grants

Funding over time

peak $1.7M · FY201024
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

DOD$2,815,867 · 7
NIH$1,093,037 · 5

By mechanism

$2,815,867 · 7
N01$985,560 · 4
R03$107,477 · 1

Investigators at University Of Saskatchewan

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Largest grants

MELANIZED FUNGI AS DISCRIMINATORS FOR NUCLEAR FALLOUT RADIONUCLIDES$1,047,555
· FY2017 · Defense Threat Reduction Agency
INVESTIGATION OF RADIATION RESISTANCE MECHANISMS IN MELANIZED FUNGI$692,030
· FY2017 · Defense Threat Reduction Agency
Task C04: Development of a Human Intestinal Enteroid Monolayer Culture System for Human Norovirus$540,623
N01 · FY2018 · AI
GRANT$344,579
· FY2024 · Department of the Army
JAPANESE ENCEPHALITIS VIRUS INFECTION IN THE NATURAL AMPLIFIYING HOST DURING PREGNANCY: IMPLICATIONS FOR THE EMERGENCE OF MORE PATHOGENIC VIRUS VARIANTS$219,705
· FY2021 · Defense Health Agency
Task C04: Development of a Human Intestinal Enteroid Monolayer Culture System for Human Norovirus$212,147
N01 · FY2020 · AI
Task C04: Development of a Human Intestinal Enteroid Monolayer Culture System for Human Norovirus$212,147
N01 · FY2021 · AI
EFFECT OF VARIATIONS IN BCG VACCINE CAPSULE POLYSACCHARIDES ON IMMUNOGENICITY AND PROTECTIVE EFFICACY$194,734
· FY2018 · Department of the Army
INTERMITTENT HYPOXIA ELICITS PROLONGED RESTORATION OF MOTOR FUNCTION IN HUMAN SCI$192,264
· FY2010 · Department of the Army
TAS::57 3600::TAS "FLUID MODELING OF INSTABILITIES AND STRUCTURES IN HALL PLASMAS" DATED 28 JAN 2015 (THE GRANTEE'S TECHNICAL PROPOSAL); IS HEREBY$125,000
· FY2015 · Department of Defense
Development of an Inducible Conditional Gene Deletion Mouse Model to Study Plasma Cell Development and Longevity$54,000
R03 · FY2022 · AG
Development of an Inducible Conditional Gene Deletion Mouse Model to Study Plasma Cell Development and Longevity$53,477
R03 · FY2023 · AG
Task C01: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$5,097
N01 · FY2018 · AI
ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$3,500
N01 · FY2017 · AI
In Vitro Assessment for Antimicrobial Activity Support (Task Area A)$2,500
N01 · FY2019 · AI
Pre-Clinical Models of Infectious Diseases$2,500
N01 · FY2024 · AI
Pre-Clinical Models of Infectious Diseases$2,500
N01 · FY2024 · AI
Pre-Clinical Models of Infectious Diseases$2,500
N01 · FY2024 · AI
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development$1,023
N01 · FY2023 · AI
Preclinical Services for Biopharmaceutical Product Development$1,023
N01 · FY2023 · AI